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ABSTRACT 
Objective: The research was aimed to synthesize 1-allyl-3-(2-chlorobenzoyl) thiourea and determine its analgesic activity in mice (Mus musculus). 
Methods: The synthesis was carried out by modified Schotten-Baumann reaction, via nucleophilic substitution reaction of allylthiourea on 2-
chlorobenzoyl chloride. The analgesic test was done by writhing test on mice (Mus musculus). 
Results: Pure 1-allyl-3-(2-chlorobenzoyl) thiourea was obtained, confirmed by means of UV, IR, 1H-NMR, 13C-NMR, and MS spectroscopy. The 
compound showed better pain inhibition activity compared to diclofenac sodium, with ED50 = 15.440 mg/kg BW. 
Conclusion: The compound 1-allyl-3-(2-chlorobenzoyl) thiourea can be synthesized by one-step modified Schotten-Baumann reaction, and showed 
a good analgesic activity. The compound needs further investigation as a potential analgesic drug candidate. 
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Analgesic development entering the new age since the finding of 
opioid receptor and endogenic substance possessed the act of 
reducing pain. The synthesis of urea by Wohler in 1828 triggered the 
age of therapeutic compounds synthesis. The first product that had 
been synthesized for the purpose of pain inhibition was salicylate, 
found in plants in methyl salicylate form, then developed as other 
salicylate derivatives [1]. Thiourea group has been reported for their 
correlation to analgesic activity. Novel 1-methyl-3-(2-methyl-4-oxo-
3H-quinazolin-3-ilthiourea (fig.1 (a)) analogs have been reported for 
their analgesic and anti-inflammatory activity [2]. Another thiourea 
derivatives-benzoyl thiourea analogs-(fig. 1 (b)) have been evaluated 
for their analgesic activity in mice (Mus musculus), and showed a 
better analgesic activity compared to Na-diclofenac [3]. Compound 1-
allyl-3-(2-chlorobenzoyl) thiourea (fig. 1 (c)) has same thiourea 
pharmacophore as the previous compounds.  
Preliminary tests showed that 1-allyl-3-(2-chlorobenzoyl) thiourea 
possessed better physicochemical properties compared to benzoyl 
thiourea. Analysis using Chemdraw Ultra 8.0 and Chem3D Ultra 8.0 
showed that 1-allyl-3-(2-chlorobenzoyl) thiourea possessed CLogP 
value (lipophilic parameter) =2, 045; Etotal (electronic parameter) 
=10, 050; and CMR (steric parameter) =6, 647. Those values were 
better compared to benzoyl thiourea's, which were CLogP= 0,566; 






















Fig. 1: Compounds with thiourea pharmacophore 
 
Docking of the compound (compared to benzoyl thiourea) on the 
COX-2 receptor (pdb: 1PXX) was done by Molegro Virtual Docker 5.0. 
COX-2 known as the main isoform of cyclooxygenase enzyme 
responsible in prostanoids synthesis involved in pathological 
inflammatory processes [4]. The docking result showed that 1-allyl-
3-(2-chlorobenzoyl) thiourea possessed lower rerank score (-
82.287) compared to benzoyl thiourea (-73.158), which means 1-
allyl-3-(2-chlorobenzoyl) thiourea produced better affinity on COX-2. 
 
 
Fig. 2: Docking result of (a) Benzoylthiourea and (b) 1-allyl-3-(2-
chlorobenzoyl) thiourea on COX-2 receptor 
 
Synthesis of 1-allyl-3-(2-chlorobenzoyl) thiourea was done by 
modified Schotten-Baumann method [5]. The reaction was carried 
out by adding a solution of 2-chlorobenzoyl chloride (7 mmol) in 
tetrahydrofuran (15 ml) to a mixture of allylthiourea (8.6 mmol) and 
triethylamine (14 mmol) in tetrahydrofuran (50 ml) dropwise. The 
reaction mixture was refluxed for 5 h, and the solvent then 
evaporated. The product then washed with sodium carbonate and 
recrystallized with methanol. 
The structure of the product was determined by means of ultraviolet 
(PERKIN ELMER UV Lambda EZ 201), infrared (FTIR PERKIN ELMER 
Spectrum One), magnetic resonance (NMR JEOL ICS 400 MHz), and 
mass spectroscopy (GC/MS AGILENT 5975C). The structure 
determination was carried out at Tropical Disease Centre 
Laboratory, and Pharmaceutical Chemistry Laboratory, Airlangga 
University, Surabaya, Indonesia. This stage ensured that the 
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synthesized compound was well matched with the desired one 
[6,7]. Yield (26.2%). Mp 127-128 oC. UV (MeOH) λ (nm): 208; 226; 
280. FTIR (KBr pellet) ν cm-1: 3465; 1692; 1556; 1538; 1590-
1472; 1179; 762. 
 
Table 1: Amino acid involved in interactions between Benzoyl thiourea and 1-allyl-3-(2-chlorobenzoyl) thiourea on the COX-2 receptor 
Compound Amino acid Interactions 
Benzoyl thiourea Ala 199 Hydrogen and steric 
Ala 202 Steric 
Leu 390 Steric 
Thr 206 Steric 
Tyr 385 Steric 



















Scheme 1: Synthesis of 1-allyl-3-(2-chlorobenzoyl) thiourea 
 
1H-NMR (400 MHz; CDCl3) δ (ppm): 10.52 (s, 1H); 9.05 (s, 1H); 7.61 
(d, 1H); 7.44-7.40 (m, 2H); 7.35-7.30 (m, 1H); 5.91 (m, 1H); 5.28 (m, 
1H); 5.21 (m, 1H); 4.30-4.27 (m; 2H). [13]C-NMR (400 MHz; CDCl3) δ 
(ppm): 178.4 (C=S); 165.0 (C=O); 132.0 (C=C); 131.2 (C ipso); 130.6 
(C arom); 130.0 (C-Cl); 129.7 (C arom); 129.1 (C arom); 126.4 (C 
arom); 116.9 (C=C); 47.0 (C=C-±C). MS (EI) m/z: 252.9 (M-H)+; 155 
(C7H6ClNO)+; 139 (C7H4ClO)+; 111 (C6H4Cl)+; 75 (C6H3)+.  
The compound, then tested for its analgesic activity using the 
writhing test on mice (Mus musculus), compared to diclofenac 
sodium. The study was approved by Airlangga University Animal 
Care and Use Committee, written on the ethical clearance document 
no: 501-KE. The writhing test method is the most natural one in 
accordance with pain sensation. Chemical stimulation provides 
longer and progressive durations of pain, which always show 
characteristic responses of mice (Mus musculus) [8].  
The result showed that 1-allyl-3-(2-chlorobenzoyl) thiourea 
possessed better pain inhibition activity. The compound inhibited 
pain as much as 37.25 % (±9.54) at 6.25 mg/kgBW dose; 44.97 % 
(±10. 70) at 12.5 mg/kgBW; and 72.15 % (±12. 02) at 25 mg/kg BW 
dose. Meanwhile diclofenac sodium at 12.5 mg/kgBW dose inhibited 
pain as much as 32.50 % (±11. 95). Using probit analysis on SPSS 20, 
1-allyl-3-(2-chlorobenzoyl) thiourea showed ED50= 15.440 mg/ kg 
BW. 
Good analgesic activity showed by compound 1-allyl-3-(2-
chlorobenzoyl) thiourea indicated that structure modification by 
adding allyl group and chloro substituent on benzoyl ring, gave 
significant effect on its biological activity. Double bond addition 
effects on the better interaction of the compound on receptor are 
constituent. Halogen group often added to a structure because it’s 
steric, electronic and obstructive effect. Halogens substituent which 
is a withdrawing electron group can strengthen the bond between 
compound and receptor. The obstructive effect produced by halogen 
group can prevent metabolism reaction; therefore, lengthen the 
duration of biological activity [9, 10].  
In conclusion, we found that 1-allyl-3-(2-chlorobenzoyl) thiourea 
was a potential compound to be developed further as an analgesic 
drug candidate. 
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